AstraZeneca's (AZN) Q4 Earnings Beat, New Drugs Drive Sales

AstraZeneca plc AZN beat the Zacks Consensus Estimate for both earnings and sales in the fourth quarter of 2018. Pascal Soriot, AstraZeneca’s chief executive officer, said “AstraZeneca has returned to growth” as its product sales grew for two consecutive quarters, Per Soriot, 2019 will be marked by successful pipeline progress and commercial initiatives.